Literature DB >> 5815146

The effect of toyocamycin on cellular RNA synthesis.

A Tavitian, S C Uretsky, G Acs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5815146     DOI: 10.1016/0005-2787(69)90121-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  11 in total

1.  Deciphering deazapurine biosynthesis: pathway for pyrrolopyrimidine nucleosides toyocamycin and sangivamycin.

Authors:  Reid M McCarty; Vahe Bandarian
Journal:  Chem Biol       Date:  2008-08-25

Review 2.  Biosynthesis of pyrrolopyrimidines.

Authors:  Reid M McCarty; Vahe Bandarian
Journal:  Bioorg Chem       Date:  2012-01-31       Impact factor: 5.275

3.  In vivo transcription of rDNA spacers in Drosophila.

Authors:  V L Murtif; P M Rae
Journal:  Nucleic Acids Res       Date:  1985-05-10       Impact factor: 16.971

4.  Frequency of N-benzyladenine incorporation into major RNA fractions of tobacco cell suspensions grown at stimulatory or cytostatic cytokinin concentration.

Authors:  J P Jouanneau; B T de la Serve; C Péaud-Lenoël
Journal:  Plant Physiol       Date:  1984-03       Impact factor: 8.340

5.  Effect of toyocamycin on the synthesis of the 70S RNA of a murine retrovirus.

Authors:  C J Larsen; M Mauchauffé; R Hamelin; L Péraudeau; L Fedele; A Tavitian
Journal:  Nucleic Acids Res       Date:  1979-04       Impact factor: 16.971

Review 6.  Screening and identification of inhibitors of endoplasmic reticulum stress-induced activation of the IRE1α-XBP1 branch.

Authors:  Etsu Tashiro
Journal:  J Antibiot (Tokyo)       Date:  2019-08-09       Impact factor: 2.649

7.  Nucleolar necklaces in chick embryo fibroblast cells. I. Formation of necklaces by dichlororibobenzimidazole and other adenosine analogues that decrease RNA synthesis and degrade preribosomes.

Authors:  D Granick
Journal:  J Cell Biol       Date:  1975-05       Impact factor: 10.539

8.  Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing.

Authors:  M Ri; E Tashiro; D Oikawa; S Shinjo; M Tokuda; Y Yokouchi; T Narita; A Masaki; A Ito; J Ding; S Kusumoto; T Ishida; H Komatsu; Y Shiotsu; R Ueda; T Iwawaki; M Imoto; S Iida
Journal:  Blood Cancer J       Date:  2012-07-20       Impact factor: 11.037

9.  Nucleoli of diploid cell strains. Thei normal ultrastructure and the effects of toyocamycin and actinomycin D.

Authors:  S G Phillips; D M Phillips
Journal:  J Cell Biol       Date:  1971-06       Impact factor: 10.539

10.  Natural compounds' activity against cancer stem-like or fast-cycling melanoma cells.

Authors:  Malgorzata Sztiller-Sikorska; Kamila Koprowska; Kinga Majchrzak; Mariusz Hartman; Malgorzata Czyz
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.